Normal filopodia extension in VASP-deficient platelets upon activation by adhesive matrices or soluble agonists

Thromb Haemost. 2009 Oct;102(4):792-4. doi: 10.1160/TH09-06-0379.
No abstract available

Publication types

  • Letter

MeSH terms

  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid / pharmacology
  • Adenosine Diphosphate / pharmacology
  • Animals
  • Blood Platelets / drug effects
  • Blood Platelets / metabolism*
  • Blood Platelets / pathology
  • Cell Adhesion Molecules / genetics
  • Cell Adhesion Molecules / metabolism*
  • Cells, Cultured
  • Extracellular Matrix / metabolism
  • Fibrinogen / metabolism
  • Hemostasis
  • Mice
  • Mice, Knockout
  • Microfilament Proteins / genetics
  • Microfilament Proteins / metabolism*
  • Phosphoproteins / genetics
  • Phosphoproteins / metabolism*
  • Platelet Activation / drug effects
  • Platelet Activation / genetics
  • Pseudopodia / drug effects
  • Pseudopodia / genetics
  • Pseudopodia / ultrastructure*
  • Thromboxane A2 / analogs & derivatives
  • Thromboxane A2 / pharmacology
  • von Willebrand Factor / metabolism

Substances

  • Cell Adhesion Molecules
  • Microfilament Proteins
  • Phosphoproteins
  • vasodilator-stimulated phosphoprotein
  • von Willebrand Factor
  • Thromboxane A2
  • Adenosine Diphosphate
  • 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
  • Fibrinogen